Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Aptevo Therapeutics Inc. (APVO) had Operating Cash Flow per Share of $-42.23 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-17.41M |
|
-- |
|
-- |
|
$28.88M |
|
$-28.88M |
|
$10.23M |
|
$-18.65M |
|
$-18.65M |
|
$-18.65M |
|
$-18.65M |
|
$-17.41M |
|
$-18.65M |
|
$-28.88M |
|
$-28.31M |
|
0.28M |
|
0.28M |
|
$-62.56 |
|
$-62.56 |
|
| Balance Sheet Financials | |
$19.07M |
|
$0.90M |
|
$5.78M |
|
$24.84M |
|
$7.22M |
|
-- |
|
$5.40M |
|
$12.62M |
|
$12.22M |
|
$12.22M |
|
$12.22M |
|
0.44M |
|
| Cash Flow Statement Financials | |
$-11.73M |
|
-- |
|
$6.00M |
|
$22.64M |
|
$16.90M |
|
$-5.73M |
|
$2.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-152.61% |
|
-152.61% |
|
-75.07% |
|
-152.61% |
|
$27.65 |
|
$-42.23 |
|
|
Operating Cash Flow per Share |
$-42.23 |